Gan & Lee Pharmaceuticals. (SHA:603087)
China · Delayed Price · Currency is CNY 56.70
+2.62 (4.84%)
Jun 18, 2026, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 32.19 billion as of June 18, 2026. Its market cap has increased by 5.46% in one year.
Market Cap
32.19B
Enterprise Value
28.78B
Revenue
3.95B
Ranking
n/a
PE Ratio
31.22
Stock Price
56.70
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 32.19B, a decrease of -11.99%. That is a compound annual growth rate of -2.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 32.19B | -20.55% |
| Dec 31, 2025 | 40.52B | 53.87% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iRay Group | 34.56B |
| Andon Health | 29.67B |
| Imeik Technology Development | 27.41B |
| Intco Medical Technology | 26.76B |
| Zhende Medical | 23.21B |
| Jiangsu Hualan New Pharmaceutical Material | 21.22B |
| Winner Medical | 15.91B |
| Qingdao NovelBeam Technology | 13.98B |